The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment.

The trend of increased plasma exposure for total tucatinib did not reach statistical significance in volunteers with moderate or severe impairment compared with those with normal hepatic function, likely due to observed high variability in plasma concentrations in the volunteers with hepatic impairment (Fig. 1 ).

also in 111,027 other papers